Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

       
Total article views   HTML views PDF downloads Totals
15,823 Dovepress* 13,477+ 1,673 15,150
PubMed Central* 2,346 471 2,817
Totals 15,823 2,144 17,967
*Since 21 March 2017

View citations on PubMed Central and Google Scholar